+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
mRNA Platform Market - Global Forecast 2026-2032- Product Image
mRNA Platform Market - Global Forecast 2026-2032- Product Image
New

mRNA Platform Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 197 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5460245
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The mRNA platform market is rapidly transforming the landscape of biopharmaceutical innovation, driving strategic change across diagnostics, therapeutics, vaccines, and research products. Senior decision-makers are prioritizing operational resilience and long-term value amid evolving technology, partnerships, and regulatory environments.

Market Snapshot

The mRNA Platform Market grew from USD 19.93 billion in 2025 to USD 24.32 billion in 2026. With ongoing innovation and a strong demand for rapid clinical translation, the sector is projected to reach USD 80.98 billion by 2032 at a CAGR of 22.17%. This robust growth reflects expanding therapeutic indications, increasing prevalence of mRNA diagnostics, and an intensifying focus on scalable solutions to meet the needs of pharmaceutical, biotechnology, and academic stakeholders.

Scope & Segmentation

This report delivers comprehensive coverage of the mRNA platform ecosystem, examining the interplay between technological advancement, regulatory processes, and commercial factors. The research is organized across these key domains:

  • Product Types: Diagnostics, Drug Discovery Reagents, Research Kits, Therapeutics, Vaccines.
  • Diagnostic Subtypes: Cancer, Infectious.
  • Drug Discovery Reagents Subtypes: Screening Reagents, Transfection Reagents.
  • Research Kits Subtypes: Lipid Nanoparticles, mRNA Synthesis Kits.
  • Therapeutics Subtypes: Cardiology, Neurologic, Oncology, Rare Diseases.
  • Vaccine Subtypes: Prophylactic, Therapeutic.
  • Therapeutic Areas: Cardiology, Infectious, Neurologic, Oncology, Rare Diseases.
  • Cardiology Subtypes: Arrhythmia, Heart Failure.
  • Infectious Subtypes: COVID-19, Influenza, Rabies.
  • Neurologic Subtypes: Alzheimer’s, Parkinson’s.
  • Oncology Subtypes: Hematologic Malignancies, Solid Tumors.
  • Rare Diseases Subtypes: Genetic Disorders, Metabolic Disorders.
  • End Users: Academic Centers, Diagnostic Labs, Hospitals, Pharmaceutical Companies, Research Institutes.
  • Academic Centers Subtypes: Colleges, Universities.
  • Diagnostic Labs Subtypes: Hospital Labs, Reference Labs.
  • Hospitals Subtypes: Private, Public.
  • Pharmaceutical Companies Subtypes: Large, Small.
  • Research Institutes Subtypes: Government, Private.
  • Regions Covered: Americas, Europe, Middle East & Africa, Asia-Pacific.
  • Core Technologies: Novel lipid delivery systems, synthetic kits, analytical diagnostics, automated synthesis platforms.

Key Takeaways

  • The mRNA platform has evolved into a versatile technology underpinning multiple applications, with ecosystem participants operating across therapeutics, diagnostics, and research reagents.
  • Increasing regulatory clarity and alignment facilitate smoother clinical translation, while health economics play a larger role in defining go-to-market strategies.
  • Strategic partnerships, especially between technology developers and downstream manufacturers, drive risk reduction, faster timelines, and improved learning curves throughout the value chain.
  • Segmentation analysis shows highly variable operational and development needs, prompting suppliers to tailor offerings and invest in quality systems to meet diverse requirements.
  • Regional strengths shape manufacturing strategies and cross-border partnerships, making it essential for firms to align with local regulatory environments and infrastructure.
  • Companies building differentiated capabilities in delivery chemistry and supply chain integration position themselves as preferred partners for both clinical development and commercialization.

Tariff Impact

The 2025 introduction of United States tariffs affected mRNA supply chains and sourcing decisions. Higher costs for critical raw materials drove manufacturers to diversify vendors, explore nearshoring, and expand vertical integration. Shifts in procurement prompted investments in regional fill-finish and domestic formulation, while contract development and manufacturing organizations negotiated longer-term agreements to minimize volatility. Financially, firms prioritized margin management and process optimization, maintaining program timelines without compromising quality or compliance.

Methodology & Data Sources

This report integrates insights from primary interviews with experts in academia and manufacturing, supplemented by workshops and cross-functional validation. Secondary data includes peer-reviewed research, regulatory documents, technical white papers, and company disclosures. Analytical techniques combine qualitative analysis, process mapping, and scenario impact assessment, with rigorous validation to ensure reliability.

Why This Report Matters

  • Enables senior executives to anticipate regulatory, technological, and geographic risks while sharpening investment strategies in the mRNA platform market.
  • Supports operational decision-making with clear insights on segmentation, procurement trends, and regional supply chain management.
  • Provides validated, actionable intelligence for fostering strategic partnerships, optimizing commercial models, and sustaining competitive advantage.

Conclusion

The mRNA platform market’s trajectory will be determined by how organizations balance operational resilience, regulatory readiness, and continual innovation. Stakeholders equipped with strategic insight can leverage these dynamics to drive meaningful clinical and commercial impact across the health and life sciences ecosystem.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. mRNA Platform Market, by Product Type
8.1. Diagnostics
8.1.1. Cancer
8.1.2. Infectious
8.2. Drug Discovery Reagents
8.2.1. Screening Reagents
8.2.2. Transfection Reagents
8.3. Research Kits
8.3.1. Lipid Nanoparticles
8.3.2. MRna Synthesis Kits
8.4. Therapeutics
8.4.1. Cardiology
8.4.2. Neurologic
8.4.3. Oncology
8.4.4. Rare Diseases
8.5. Vaccines
8.5.1. Prophylactic
8.5.2. Therapeutic
9. mRNA Platform Market, by Therapeutic Area
9.1. Cardiology
9.1.1. Arrhythmia
9.1.2. Heart Failure
9.2. Infectious
9.2.1. COVID-19
9.2.2. Influenza
9.2.3. Rabies
9.3. Neurologic
9.3.1. Alzheimer’s
9.3.2. Parkinson’s
9.4. Oncology
9.4.1. Hematologic Malignancies
9.4.2. Solid Tumors
9.5. Rare Diseases
9.5.1. Genetic Disorders
9.5.2. Metabolic Disorders
10. mRNA Platform Market, by Route Of Administration
10.1. Intramuscular
10.2. Intravenous
10.3. Subcutaneous
10.4. Intradermal
10.5. Inhalation
10.6. Intranasal
11. mRNA Platform Market, by End User
11.1. Academic Centers
11.1.1. Colleges
11.1.2. Universities
11.2. Diagnostic Labs
11.2.1. Hospital Labs
11.2.2. Reference Labs
11.3. Hospitals
11.3.1. Private
11.3.2. Public
11.4. Pharmaceutical Companies
11.4.1. Large
11.4.2. Small
11.5. Research Institutes
11.5.1. Government
11.5.2. Private
12. mRNA Platform Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. mRNA Platform Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. mRNA Platform Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States mRNA Platform Market
16. China mRNA Platform Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Arcturus Therapeutics Holdings, Inc.
17.6. AstraZeneca PLC
17.7. BioNTech SE
17.8. CureVac SE
17.9. GlaxoSmithKline plc
17.10. Gritstone bio, Inc.
17.11. Lonza Group AG
17.12. Moderna, Inc.
17.13. Pfizer Inc.
17.14. Providence Therapeutics Holdings Inc.
17.15. Samsung Biologics Co., Ltd.
17.16. Sanofi S.A.
17.17. Thermo Fisher Scientific Inc.
17.18. Vaxart, Inc.
List of Figures
FIGURE 1. GLOBAL MRNA PLATFORM MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL MRNA PLATFORM MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL MRNA PLATFORM MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL MRNA PLATFORM MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL MRNA PLATFORM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL MRNA PLATFORM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL MRNA PLATFORM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL MRNA PLATFORM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL MRNA PLATFORM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES MRNA PLATFORM MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA MRNA PLATFORM MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL MRNA PLATFORM MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL MRNA PLATFORM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL MRNA PLATFORM MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL MRNA PLATFORM MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL MRNA PLATFORM MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL MRNA PLATFORM MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL MRNA PLATFORM MARKET SIZE, BY CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL MRNA PLATFORM MARKET SIZE, BY CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL MRNA PLATFORM MARKET SIZE, BY CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL MRNA PLATFORM MARKET SIZE, BY DRUG DISCOVERY REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL MRNA PLATFORM MARKET SIZE, BY DRUG DISCOVERY REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL MRNA PLATFORM MARKET SIZE, BY DRUG DISCOVERY REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL MRNA PLATFORM MARKET SIZE, BY DRUG DISCOVERY REAGENTS, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL MRNA PLATFORM MARKET SIZE, BY SCREENING REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL MRNA PLATFORM MARKET SIZE, BY SCREENING REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL MRNA PLATFORM MARKET SIZE, BY SCREENING REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL MRNA PLATFORM MARKET SIZE, BY TRANSFECTION REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL MRNA PLATFORM MARKET SIZE, BY TRANSFECTION REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL MRNA PLATFORM MARKET SIZE, BY TRANSFECTION REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL MRNA PLATFORM MARKET SIZE, BY RESEARCH KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL MRNA PLATFORM MARKET SIZE, BY RESEARCH KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL MRNA PLATFORM MARKET SIZE, BY RESEARCH KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL MRNA PLATFORM MARKET SIZE, BY RESEARCH KITS, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL MRNA PLATFORM MARKET SIZE, BY LIPID NANOPARTICLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL MRNA PLATFORM MARKET SIZE, BY LIPID NANOPARTICLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL MRNA PLATFORM MARKET SIZE, BY LIPID NANOPARTICLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL MRNA PLATFORM MARKET SIZE, BY MRNA SYNTHESIS KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL MRNA PLATFORM MARKET SIZE, BY MRNA SYNTHESIS KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL MRNA PLATFORM MARKET SIZE, BY MRNA SYNTHESIS KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL MRNA PLATFORM MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL MRNA PLATFORM MARKET SIZE, BY THERAPEUTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL MRNA PLATFORM MARKET SIZE, BY THERAPEUTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL MRNA PLATFORM MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL MRNA PLATFORM MARKET SIZE, BY VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL MRNA PLATFORM MARKET SIZE, BY VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL MRNA PLATFORM MARKET SIZE, BY VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL MRNA PLATFORM MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL MRNA PLATFORM MARKET SIZE, BY PROPHYLACTIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL MRNA PLATFORM MARKET SIZE, BY PROPHYLACTIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL MRNA PLATFORM MARKET SIZE, BY PROPHYLACTIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL MRNA PLATFORM MARKET SIZE, BY ARRHYTHMIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL MRNA PLATFORM MARKET SIZE, BY ARRHYTHMIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL MRNA PLATFORM MARKET SIZE, BY ARRHYTHMIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL MRNA PLATFORM MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL MRNA PLATFORM MARKET SIZE, BY HEART FAILURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL MRNA PLATFORM MARKET SIZE, BY HEART FAILURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL MRNA PLATFORM MARKET SIZE, BY COVID-19, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL MRNA PLATFORM MARKET SIZE, BY COVID-19, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL MRNA PLATFORM MARKET SIZE, BY COVID-19, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL MRNA PLATFORM MARKET SIZE, BY INFLUENZA, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL MRNA PLATFORM MARKET SIZE, BY INFLUENZA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL MRNA PLATFORM MARKET SIZE, BY INFLUENZA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL MRNA PLATFORM MARKET SIZE, BY RABIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL MRNA PLATFORM MARKET SIZE, BY RABIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL MRNA PLATFORM MARKET SIZE, BY RABIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL MRNA PLATFORM MARKET SIZE, BY ALZHEIMER’S, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL MRNA PLATFORM MARKET SIZE, BY ALZHEIMER’S, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL MRNA PLATFORM MARKET SIZE, BY ALZHEIMER’S, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL MRNA PLATFORM MARKET SIZE, BY PARKINSON’S, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL MRNA PLATFORM MARKET SIZE, BY PARKINSON’S, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL MRNA PLATFORM MARKET SIZE, BY PARKINSON’S, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL MRNA PLATFORM MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL MRNA PLATFORM MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL MRNA PLATFORM MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL MRNA PLATFORM MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL MRNA PLATFORM MARKET SIZE, BY SOLID TUMORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL MRNA PLATFORM MARKET SIZE, BY SOLID TUMORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL MRNA PLATFORM MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL MRNA PLATFORM MARKET SIZE, BY GENETIC DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL MRNA PLATFORM MARKET SIZE, BY GENETIC DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL MRNA PLATFORM MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL MRNA PLATFORM MARKET SIZE, BY METABOLIC DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL MRNA PLATFORM MARKET SIZE, BY METABOLIC DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL MRNA PLATFORM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL MRNA PLATFORM MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL MRNA PLATFORM MARKET SIZE, BY INTRAMUSCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL MRNA PLATFORM MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL MRNA PLATFORM MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL MRNA PLATFORM MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL MRNA PLATFORM MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL MRNA PLATFORM MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL MRNA PLATFORM MARKET SIZE, BY SUBCUTANEOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL MRNA PLATFORM MARKET SIZE, BY SUBCUTANEOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL MRNA PLATFORM MARKET SIZE, BY INTRADERMAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL MRNA PLATFORM MARKET SIZE, BY INTRADERMAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL MRNA PLATFORM MARKET SIZE, BY INTRADERMAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL MRNA PLATFORM MARKET SIZE, BY INHALATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL MRNA PLATFORM MARKET SIZE, BY INHALATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL MRNA PLATFORM MARKET SIZE, BY INHALATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL MRNA PLATFORM MARKET SIZE, BY INTRANASAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL MRNA PLATFORM MARKET SIZE, BY INTRANASAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL MRNA PLATFORM MARKET SIZE, BY INTRANASAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL MRNA PLATFORM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL MRNA PLATFORM MARKET SIZE, BY ACADEMIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL MRNA PLATFORM MARKET SIZE, BY ACADEMIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL MRNA PLATFORM MARKET SIZE, BY ACADEMIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL MRNA PLATFORM MARKET SIZE, BY ACADEMIC CENTERS, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL MRNA PLATFORM MARKET SIZE, BY COLLEGES, BY REGION, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL MRNA PLATFORM MARKET SIZE, BY COLLEGES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL MRNA PLATFORM MARKET SIZE, BY COLLEGES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL MRNA PLATFORM MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL MRNA PLATFORM MARKET SIZE, BY UNIVERSITIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL MRNA PLATFORM MARKET SIZE, BY UNIVERSITIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL MRNA PLATFORM MARKET SIZE, BY DIAGNOSTIC LABS, BY REGION, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL MRNA PLATFORM MARKET SIZE, BY DIAGNOSTIC LABS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL MRNA PLATFORM MARKET SIZE, BY DIAGNOSTIC LABS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL MRNA PLATFORM MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL MRNA PLATFORM MARKET SIZE, BY HOSPITAL LABS, BY REGION, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL MRNA PLATFORM MARKET SIZE, BY HOSPITAL LABS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL MRNA PLATFORM MARKET SIZE, BY HOSPITAL LABS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL MRNA PLATFORM MARKET SIZE, BY REFERENCE LABS, BY REGION, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL MRNA PLATFORM MARKET SIZE, BY REFERENCE LABS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL MRNA PLATFORM MARKET SIZE, BY REFERENCE LABS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL MRNA PLATFORM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL MRNA PLATFORM MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL MRNA PLATFORM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL MRNA PLATFORM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL MRNA PLATFORM MARKET SIZE, BY PRIVATE, BY REGION, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL MRNA PLATFORM MARKET SIZE, BY PRIVATE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL MRNA PLATFORM MARKET SIZE, BY PRIVATE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL MRNA PLATFORM MARKET SIZE, BY PUBLIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL MRNA PLATFORM MARKET SIZE, BY PUBLIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL MRNA PLATFORM MARKET SIZE, BY PUBLIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. GLOBAL MRNA PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL MRNA PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 165. GLOBAL MRNA PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 166. GLOBAL MRNA PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 167. GLOBAL MRNA PLATFORM MARKET SIZE, BY LARGE, BY REGION, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL MRNA PLATFORM MARKET SIZE, BY LARGE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 169. GLOBAL MRNA PLATFORM MARKET SIZE, BY LARGE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL MRNA PLATFORM MARKET SIZE, BY SMALL, BY REGION, 2018-2032 (USD MILLION)
TABLE 171. GLOBAL MRNA PLATFORM MARKET SIZE, BY SMALL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 172. GLOBAL MRNA PLATFORM MARKET SIZE, BY SMALL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 173. GLOBAL MRNA PLATFORM MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 174. GLOBAL MRNA PLATFORM MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 175. GLOBAL MRNA PLATFORM MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 176. GLOBAL MRNA PLATFORM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 177. GLOBAL MRNA PLATFORM MARKET SIZE, BY GOVERNMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 178. GLOBAL MRNA PLATFORM MARKET SIZE, BY GOVERNMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 179. GLOBAL MRNA PLATFORM MARKET SIZE, BY GOVERNMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 180. GLOBAL MRNA PLATFORM MARKET SIZE, BY PRIVATE, BY REGION, 2018-2032 (USD MILLION)
TABLE 181. GLOBAL MRNA PLATFORM MARKET SIZE, BY PRIVATE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 182. GLOBAL MRNA PLATFORM MARKET SIZE, BY PRIVATE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 183. GLOBAL MRNA PLATFORM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 184. AMERICAS MRNA PLATFORM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 185. AMERICAS MRNA PLATFORM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 186. AMERICAS MRNA PLATFORM MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 187. AMERICAS MRNA PLATFORM MARKET SIZE, BY DRUG DISCOVERY REAGENTS, 2018-2032 (USD MILLION)
TABLE 188. AMERICAS MRNA PLATFORM MARKET SIZE, BY RESEARCH KITS, 2018-2032 (USD MILLION)
TABLE 189. AMERICAS MRNA PLATFORM MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 190. AMERICAS MRNA PLATFORM MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 191. AMERICAS MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 192. AMERICAS MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 193. AMERICAS MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, 2018-2032 (USD MILLION)
TABLE 194. AMERICAS MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, 2018-2032 (USD MILLION)
TABLE 195. AMERICAS MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 196. AMERICAS MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, 2018-2032 (USD MILLION)
TABLE 197. AMERICAS MRNA PLATFORM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 198. AMERICAS MRNA PLATFORM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 199. AMERICAS MRNA PLATFORM MARKET SIZE, BY ACADEMIC CENTERS, 2018-2032 (USD MILLION)
TABLE 200. AMERICAS MRNA PLATFORM MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
TABLE 201. AMERICAS MRNA PLATFORM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 202. AMERICAS MRNA PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 203. AMERICAS MRNA PLATFORM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 204. NORTH AMERICA MRNA PLATFORM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 205. NORTH AMERICA MRNA PLATFORM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 206. NORTH AMERICA MRNA PLATFORM MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 207. NORTH AMERICA MRNA PLATFORM MARKET SIZE, BY DRUG DISCOVERY REAGENTS, 2018-2032 (USD MILLION)
TABLE 208. NORTH AMERICA MRNA PLATFORM MARKET SIZE, BY RESEARCH KITS, 2018-2032 (USD MILLION)
TABLE 209. NORTH AMERICA MRNA PLATFORM MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 210. NORTH AMERICA MRNA PLATFORM MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 211. NORTH AMERICA MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 212. NORTH AMERICA MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 213. NORTH AMERICA MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, 2018-2032 (USD MILLION)
TABLE 214. NORTH AMERICA MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, 2018-2032 (USD MILLION)
TABLE 215. NORTH AMERICA MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 216. NORTH AMERICA MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, 2018-2032 (USD MILLION)
TABLE 217. NORTH AMERICA MRNA PLATFORM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 218. NORTH AMERICA MRNA PLATFORM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 219. NORTH AMERICA MRNA PLATFORM MARKET SIZE, BY ACADEMIC CENTERS, 2018-2032 (USD MILLION)
TABLE 220. NORTH AMERICA MRNA PLATFORM MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
TABLE 221. NORTH AMERICA MRNA PLATFORM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 222. NORTH AMERICA MRNA PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 223. NORTH AMERICA MRNA PLATFORM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 224. LATIN AMERICA MRNA PLATFORM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 225. LATIN AMERICA MRNA PLATFORM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 226. LATIN AMERICA MRNA PLATFORM MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 227. LATIN AMERICA MRNA PLATFORM MARKET SIZE, BY DRUG DISCOVERY REAGENTS, 2018-2032 (USD MILLION)
TABLE 228. LATIN AMERICA MRNA PLATFORM MARKET SIZE, BY RESEARCH KITS, 2018-2032 (USD MILLION)
TABLE 229. LATIN AMERICA MRNA PLATFORM MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 230. LATIN AMERICA MRNA PLATFORM MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 231. LATIN AMERICA MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 232. LATIN AMERICA MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 233. LATIN AMERICA MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, 2018-2032 (USD MILLION)
TABLE 234. LATIN AMERICA MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, 2018-2032 (USD MILLION)
TABLE 235. LATIN AMERICA MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 236. LATIN AMERICA MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, 2018-2032 (USD MILLION)
TABLE 237. LATIN AMERICA MRNA PLATFORM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 238. LATIN AMERICA MRNA PLATFORM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 239. LATIN AMERICA MRNA PLATFORM MARKET SIZE, BY ACADEMIC CENTERS, 2018-2032 (USD MILLION)
TABLE 240. LATIN AMERICA MRNA PLATFORM MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
TABLE 241. LATIN AMERICA MRNA PLATFORM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 242. LATIN AMERICA MRNA PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 243. LATIN AMERICA MRNA PLATFORM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY DRUG DISCOVERY REAGENTS, 2018-2032 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY RESEARCH KITS, 2018-2032 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, 2018-2032 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, 2018-2032 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, 2018-2032 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY ACADEMIC CENTERS, 2018-2032 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 264. EUROPE MRNA PLATFORM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 265. EUROPE MRNA PLATFORM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 266. EUROPE MRNA PLATFORM MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 267. EUROPE MRNA PLATFORM MARKET SIZE, BY DRUG DISCOVERY REAGENTS, 2018-2032 (USD MILLION)
TABLE 268. EUROPE MRNA PLATFORM MARKET SIZE, BY RESEARCH KITS, 2018-2032 (USD MILLION)
TABLE 269. EUROPE MRNA PLATFORM MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 270. EUROPE MRNA PLATFORM MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 271. EUROPE MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 272. EUROPE MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 273. EUROPE MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, 2018-2032 (USD MILLION)
TABLE 274. EUROPE MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, 2018-2032 (USD MILLION)
TABLE 275. EUROPE MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 276. EUROPE MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, 2018-2032 (USD MILLION)
TABLE 277. EUROPE MRNA PLATFORM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 278. EUROPE MRNA PLATFORM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 279. EUROPE MRNA PLATFORM MARKET SIZE, BY ACADEMIC CENTERS, 2018-2032 (USD MILLION)
TABLE 280. EUROPE MRNA PLATFORM MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
TABLE 281. EUROPE MRNA PLATFORM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 282. EUROPE MRNA PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 283. EUROPE MRNA PLATFORM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 284. MIDDLE EAST MRNA PLATFORM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 285. MIDDLE EAST MRNA PLATFORM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 286. MIDDLE EAST MRNA PLATFORM MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 287. MIDDLE EAST MRNA PLATFORM MARKET SIZE, BY DRUG DISCOVERY REAGENTS, 2018-2032 (USD MILLION)
TABLE 288. MIDDLE EAST MRNA PLATFORM MARKET SIZE, BY RESEARCH KITS, 2018-2032 (USD MILLION)
TABLE 289. MIDDLE EAST MRNA PLATFORM MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 290. MIDDLE EAST MRNA PLATFORM MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 291. MIDDLE EAST MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 292. MIDDLE EAST MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 293. MIDDLE EAST MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, 2018-2032 (USD MILLION)
TABLE 294. MIDDLE EAST MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, 2018-2032 (USD MILLION)
TABLE 295. MIDDLE EAST MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 296. MIDDLE EAST MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, 2018-2032 (USD MILLION)
TABLE 297. MIDDLE EAST MRNA PLATFORM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 298. MIDDLE EAST MRNA PLATFORM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 299. MIDDLE EAST MRNA PLATFORM MARKET SIZE, BY ACADEMIC CENTERS, 2018-2032 (USD MILLION)
TABLE 300. MIDDLE EAST MRNA PLATFORM MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
TABLE 301. MIDDLE EAST MRNA PLATFORM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 302. MIDDLE EAST MRNA PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 303. MIDDLE EAST MRNA PLATFORM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 304. AFRICA MRNA PLATFORM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 305. AFRICA MRNA PLATFORM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 306. AFRICA MRNA PLATFORM MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 307. AFRICA MRNA PLATFORM MARKET SIZE, BY DRUG DISCOVERY REAGENTS, 2018-2032 (USD MILLION)
TABLE 308. AFRICA MRNA PLATFORM MARKET SIZE, BY RESEARCH KITS, 2018-2032 (USD MILLION)
TABLE 309. AFRICA MRNA PLATFORM MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 310. AFRICA MRNA PLATFORM MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 311. AFRICA MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 312. AFRICA MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 313. AFRICA MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, 2018-2032 (USD MILLION)
TABLE 314. AFRICA MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, 2018-2032 (USD MILLION)
TABLE 315. AFRICA MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 316. AFRICA MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, 2018-2032 (USD MILLION)
TABLE 317. AFRICA MRNA PLATFORM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 318. AFRICA MRNA PLATFORM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 319. AFRICA MRNA PLATFORM MARKET SIZE, BY ACADEMIC CENTERS, 2018-2032 (USD MILLION)
TABLE 320. AFRICA MRNA PLATFORM MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
TABLE 321. AFRICA MRNA PLATFORM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 322. AFRICA MRNA PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 323. AFRICA MRNA PLATFORM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 324. ASIA-PACIFIC MRNA PLATFORM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 325. ASIA-PACIFIC MRNA PLATFORM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 326. ASIA-PACIFIC MRNA PLATFORM MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 327. ASIA-PACIFIC MRNA PLATFORM MARKET SIZE, BY DRUG DISCOVERY REAGENTS, 2018-2032 (USD MILLION)
TABLE 328. ASIA-PACIFIC MRNA PLATFORM MARKET SIZE, BY RESEARCH KITS, 2018-2032 (USD MILLION)
TABLE 329. ASIA-PACIFIC MRNA PLATFORM MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 330. ASIA-PACIFIC MRNA PLATFORM MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 331. ASIA-PACIFIC MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 332. ASIA-PACIFIC MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 333. ASIA-PACIFIC MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, 2018-2032 (USD MILLION)
TABLE 334. ASIA-PACIFIC MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, 2018-2032 (USD MILLION)
TABLE 335. ASIA-PACIFIC MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 336. ASIA-PACIFIC MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, 2018-2032 (USD MILLION)
TABLE 337. ASIA-PACIFIC MRNA PLATFORM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 338. ASIA-PACIFIC MRNA PLATFORM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 339. ASIA-PACIFIC MRNA PLATFORM MARKET SIZE, BY ACADEMIC CENTERS, 2018-2032 (USD MILLION)
TABLE 340. ASIA-PACIFIC MRNA PLATFORM MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
TABLE 341. ASIA-PACIFIC MRNA PLATFORM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 342. ASIA-PACIFIC MRNA PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 343. ASIA-PACIFIC MRNA PLATFORM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 344. GLOBAL MRNA PLATFORM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 345. ASEAN MRNA PLATFORM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 346. ASEAN MRNA PLATFORM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 347. ASEAN MRNA PLATFORM MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 348. ASEAN MRNA PLATFORM MARKET SIZE,

Companies Mentioned

The key companies profiled in this mRNA Platform market report include:
  • Arcturus Therapeutics Holdings, Inc.
  • AstraZeneca PLC
  • BioNTech SE
  • CureVac SE
  • GlaxoSmithKline plc
  • Gritstone bio, Inc.
  • Lonza Group AG
  • Moderna, Inc.
  • Pfizer Inc.
  • Providence Therapeutics Holdings Inc.
  • Samsung Biologics Co., Ltd.
  • Sanofi S.A.
  • Thermo Fisher Scientific Inc.
  • Vaxart, Inc.

Table Information

Report AttributeDetails
No. of Pages197
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 24.32 Billion
Forecasted Market Value ( USD ) by 2032 $ 80.98 Billion
Compound Annual Growth Rate22.1%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

mRNA Vaccines Market - Global Forecast 2025-2032 - Product Image

mRNA Vaccines Market - Global Forecast 2025-2032

  • Report
  • 183 Pages
  • Global
From
mRNA Vaccine Drugs Development Services Market - Global Forecast 2026-2032 - Product Image

mRNA Vaccine Drugs Development Services Market - Global Forecast 2026-2032

  • Report
  • 185 Pages
  • Global
From
mRNA Platform Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

mRNA Platform Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
mRNA Platform - Global Strategic Business Report - Product Image

mRNA Platform - Global Strategic Business Report

  • Report
  • 164 Pages
  • Global
From
mRNA Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

mRNA Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 188 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.